Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SillyPoint
    Member
    • May 2008
    • 39

    #1

    ONT error model and quality scoring

    Regarding ONT's new technology, I think I heard the following over the last few days (please correct if I've mis-heard):
    • Error rate is 4% today, targeting 1% by release.
    • Predominant error is a deletion.
    • Output (e.g., from MinION) is in fastq format.

    4% of what? Given an error model including deletions, one possible interpretation is that there is a 4% chance that a given base will be missed. ONT, is that what you mean?

    More to the point: What observable aspects of the process are used in computing quality scores? We've been shown (sort of) how current traces can be converted into basecalls. What residue of that information is used in generating confidence estimates? If we knew that, we could better understand what use we can make of the scores.

    In any case, a fastq format doesn't seem appropriate. This isn't the Illumina error model, where you want to quantify by Q score the likelihood that a basecall at a given position is wrong. If I see a score of Q14 at some position in an ONT fastq file, does that mean there's a 4% chance that (1) the base was called wrong, (2) a base was missed following, or (3) prior to this position? How do I encode the case of miscall-plus-two-deletions at a given position?

    --TS

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...